A photo from open sources Employees of the Boston Northeast US University reported that they found an antibiotic teixobactin, not addictive to pathogenic bacteria. During laboratory studies, scientists found that the resulting drug able to overcome the dangerous bacteria caused by staphylococcus and pathogens of tuberculosis. In addition, teixobactin does not cause bacteria mutations. “The properties of this compound indicate the path to antibiotics that are most likely to avoid producing sustainability. This circumstance will solve the problem. the resistance (resistance) of bacteria to antibiotics, which spreads faster than the introduction into clinical practice of new medications “, – noted in the Boston Northeast US University. Americans new medicine with scientists from the UK and Germany tested on rodents. On that to prepare and conduct human trials may go away some years.
USA
